nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—DRD5—bipolar disorder	0.417	0.506	CbGaD
Zuclopenthixol—DRD1—bipolar disorder	0.181	0.219	CbGaD
Zuclopenthixol—DRD2—bipolar disorder	0.127	0.155	CbGaD
Zuclopenthixol—HTR2A—bipolar disorder	0.0983	0.119	CbGaD
Zuclopenthixol—DRD1—telencephalic ventricle—bipolar disorder	0.00625	0.153	CbGeAlD
Zuclopenthixol—HTR2A—locus ceruleus—bipolar disorder	0.00513	0.126	CbGeAlD
Zuclopenthixol—DRD2—telencephalic ventricle—bipolar disorder	0.00369	0.0906	CbGeAlD
Zuclopenthixol—HTR2A—autonomic nervous system—bipolar disorder	0.00273	0.067	CbGeAlD
Zuclopenthixol—HTR2A—telencephalic ventricle—bipolar disorder	0.00243	0.0598	CbGeAlD
Zuclopenthixol—HTR2A—urine—bipolar disorder	0.00222	0.0546	CbGeAlD
Zuclopenthixol—CYP2D6—urine—bipolar disorder	0.00203	0.0497	CbGeAlD
Zuclopenthixol—ADRA2A—blood plasma—bipolar disorder	0.00136	0.0335	CbGeAlD
Zuclopenthixol—HTR6—nervous system—bipolar disorder	0.00119	0.0292	CbGeAlD
Zuclopenthixol—HTR2A—blood plasma—bipolar disorder	0.00116	0.0285	CbGeAlD
Zuclopenthixol—DRD5—nervous system—bipolar disorder	0.00116	0.0285	CbGeAlD
Zuclopenthixol—CYP2D6—blood plasma—bipolar disorder	0.00106	0.026	CbGeAlD
Zuclopenthixol—HTR6—brain—bipolar disorder	0.00091	0.0223	CbGeAlD
Zuclopenthixol—DRD5—brain—bipolar disorder	0.000886	0.0218	CbGeAlD
Zuclopenthixol—DRD1—nervous system—bipolar disorder	0.000886	0.0217	CbGeAlD
Zuclopenthixol—DRD1—brain—bipolar disorder	0.000677	0.0166	CbGeAlD
Zuclopenthixol—ADRA1A—nervous system—bipolar disorder	0.000534	0.0131	CbGeAlD
Zuclopenthixol—DRD2—nervous system—bipolar disorder	0.000523	0.0128	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—bipolar disorder	0.000502	0.0123	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—bipolar disorder	0.000492	0.0121	CbGeAlD
Zuclopenthixol—ADRA2A—thyroid gland—bipolar disorder	0.000483	0.0118	CbGeAlD
Zuclopenthixol—HRH1—nervous system—bipolar disorder	0.000413	0.0101	CbGeAlD
Zuclopenthixol—ADRA1A—brain—bipolar disorder	0.000408	0.01	CbGeAlD
Zuclopenthixol—ADRA2A—nervous system—bipolar disorder	0.000406	0.00997	CbGeAlD
Zuclopenthixol—DRD2—brain—bipolar disorder	0.0004	0.00982	CbGeAlD
Zuclopenthixol—ADRA2A—cerebellum—bipolar disorder	0.000382	0.00938	CbGeAlD
Zuclopenthixol—HTR2A—nervous system—bipolar disorder	0.000345	0.00847	CbGeAlD
Zuclopenthixol—HTR2A—cerebellum—bipolar disorder	0.000325	0.00797	CbGeAlD
Zuclopenthixol—HRH1—brain—bipolar disorder	0.000316	0.00776	CbGeAlD
Zuclopenthixol—CYP2D6—nervous system—bipolar disorder	0.000314	0.00772	CbGeAlD
Zuclopenthixol—ADRA2A—brain—bipolar disorder	0.00031	0.00762	CbGeAlD
Zuclopenthixol—CYP2D6—cerebellum—bipolar disorder	0.000296	0.00726	CbGeAlD
Zuclopenthixol—HTR2A—brain—bipolar disorder	0.000264	0.00648	CbGeAlD
Zuclopenthixol—CYP2D6—brain—bipolar disorder	0.00024	0.0059	CbGeAlD
Zuclopenthixol—Flupentixol—DRD1—bipolar disorder	0.000222	0.0276	CrCbGaD
Zuclopenthixol—Acetophenazine—DRD1—bipolar disorder	0.000197	0.0245	CrCbGaD
Zuclopenthixol—Propericiazine—DRD1—bipolar disorder	0.000174	0.0217	CrCbGaD
Zuclopenthixol—Loxapine—DRD5—bipolar disorder	0.00017	0.0212	CrCbGaD
Zuclopenthixol—Quetiapine—DRD5—bipolar disorder	0.000166	0.0207	CrCbGaD
Zuclopenthixol—Flupentixol—DRD2—bipolar disorder	0.000156	0.0195	CrCbGaD
Zuclopenthixol—Domperidone—DRD3—bipolar disorder	0.000152	0.0189	CrCbGaD
Zuclopenthixol—Acetophenazine—DRD2—bipolar disorder	0.000139	0.0173	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD5—bipolar disorder	0.000135	0.0167	CrCbGaD
Zuclopenthixol—Flupentixol—HTR2A—bipolar disorder	0.000121	0.015	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A3—bipolar disorder	0.000118	0.0146	CrCbGaD
Zuclopenthixol—Amoxapine—DRD4—bipolar disorder	0.000112	0.0139	CrCbGaD
Zuclopenthixol—Thioproperazine—DRD1—bipolar disorder	0.000109	0.0136	CrCbGaD
Zuclopenthixol—Thiothixene—DRD1—bipolar disorder	0.000108	0.0134	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD1—bipolar disorder	0.000108	0.0134	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2C—bipolar disorder	0.000106	0.0132	CrCbGaD
Zuclopenthixol—Domperidone—DRD2—bipolar disorder	0.000105	0.0131	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD3—bipolar disorder	0.000105	0.013	CrCbGaD
Zuclopenthixol—Nefazodone—HTR1A—bipolar disorder	0.000103	0.0128	CrCbGaD
Zuclopenthixol—Trazodone—HTR2C—bipolar disorder	9.81e-05	0.0122	CrCbGaD
Zuclopenthixol—Amoxapine—DRD3—bipolar disorder	9.63e-05	0.012	CrCbGaD
Zuclopenthixol—Trazodone—HTR1A—bipolar disorder	9.53e-05	0.0119	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD3—bipolar disorder	9.47e-05	0.0118	CrCbGaD
Zuclopenthixol—Amoxapine—DRD1—bipolar disorder	9.45e-05	0.0118	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD1—bipolar disorder	9.29e-05	0.0116	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2C—bipolar disorder	9.2e-05	0.0114	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR1A—bipolar disorder	9.08e-05	0.0113	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A3—bipolar disorder	8.96e-05	0.0111	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR1A—bipolar disorder	8.93e-05	0.0111	CrCbGaD
Zuclopenthixol—Thiothixene—HTR1A—bipolar disorder	8.93e-05	0.0111	CrCbGaD
Zuclopenthixol—Prochlorperazine—HTR2C—bipolar disorder	8.79e-05	0.0109	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A4—bipolar disorder	8.79e-05	0.0109	CrCbGaD
Zuclopenthixol—Loxapine—DRD4—bipolar disorder	8.72e-05	0.0109	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD3—bipolar disorder	8.62e-05	0.0107	CrCbGaD
Zuclopenthixol—Quetiapine—DRD4—bipolar disorder	8.51e-05	0.0106	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD1—bipolar disorder	8.46e-05	0.0105	CrCbGaD
Zuclopenthixol—Trazodone—SLC6A4—bipolar disorder	8.13e-05	0.0101	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2C—bipolar disorder	8.09e-05	0.0101	CrCbGaD
Zuclopenthixol—Thioridazine—DRD1—bipolar disorder	8.01e-05	0.00996	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2C—bipolar disorder	7.95e-05	0.00989	CrCbGaD
Zuclopenthixol—Amoxapine—HTR1A—bipolar disorder	7.85e-05	0.00977	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR1A—bipolar disorder	7.72e-05	0.0096	CrCbGaD
Zuclopenthixol—Thioproperazine—DRD2—bipolar disorder	7.7e-05	0.00959	CrCbGaD
Zuclopenthixol—Thiothixene—DRD2—bipolar disorder	7.58e-05	0.00943	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD2—bipolar disorder	7.58e-05	0.00943	CrCbGaD
Zuclopenthixol—Loxapine—DRD3—bipolar disorder	7.52e-05	0.00936	CrCbGaD
Zuclopenthixol—Loxapine—DRD1—bipolar disorder	7.38e-05	0.00918	CrCbGaD
Zuclopenthixol—Perphenazine—DRD1—bipolar disorder	7.35e-05	0.00914	CrCbGaD
Zuclopenthixol—Quetiapine—DRD3—bipolar disorder	7.34e-05	0.00913	CrCbGaD
Zuclopenthixol—Clozapine—DRD4—bipolar disorder	7.32e-05	0.00911	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD2—bipolar disorder	7.24e-05	0.00901	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2C—bipolar disorder	7.24e-05	0.00901	CrCbGaD
Zuclopenthixol—Quetiapine—DRD1—bipolar disorder	7.2e-05	0.00896	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A3—bipolar disorder	7e-05	0.00871	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD4—bipolar disorder	6.89e-05	0.00857	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2C—bipolar disorder	6.85e-05	0.00852	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—bipolar disorder	6.75e-05	0.0084	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—bipolar disorder	6.7e-05	0.00834	CrCbGaD
Zuclopenthixol—Amoxapine—DRD2—bipolar disorder	6.66e-05	0.00829	CrCbGaD
Zuclopenthixol—Thioridazine—HTR1A—bipolar disorder	6.65e-05	0.00827	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD2—bipolar disorder	6.55e-05	0.00815	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2C—bipolar disorder	6.35e-05	0.00791	CrCbGaD
Zuclopenthixol—Loxapine—HTR2C—bipolar disorder	6.31e-05	0.00786	CrCbGaD
Zuclopenthixol—Clozapine—DRD3—bipolar disorder	6.31e-05	0.00786	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2C—bipolar disorder	6.29e-05	0.00782	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—bipolar disorder	6.25e-05	0.00778	CrCbGaD
Zuclopenthixol—Clozapine—DRD1—bipolar disorder	6.2e-05	0.00771	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR1A—bipolar disorder	6.17e-05	0.00768	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2C—bipolar disorder	6.16e-05	0.00767	CrCbGaD
Zuclopenthixol—Loxapine—HTR1A—bipolar disorder	6.13e-05	0.00763	CrCbGaD
Zuclopenthixol—Perphenazine—HTR1A—bipolar disorder	6.1e-05	0.00759	CrCbGaD
Zuclopenthixol—Quetiapine—HTR1A—bipolar disorder	5.98e-05	0.00744	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD2—bipolar disorder	5.96e-05	0.00742	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—bipolar disorder	5.95e-05	0.00741	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD3—bipolar disorder	5.94e-05	0.00739	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—bipolar disorder	5.86e-05	0.00729	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—bipolar disorder	5.86e-05	0.00729	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD1—bipolar disorder	5.83e-05	0.00725	CrCbGaD
Zuclopenthixol—Thioridazine—DRD2—bipolar disorder	5.64e-05	0.00702	CrCbGaD
Zuclopenthixol—Clozapine—HTR2C—bipolar disorder	5.3e-05	0.0066	CrCbGaD
Zuclopenthixol—Trifluoperazine—DRD2—bipolar disorder	5.24e-05	0.00652	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A4—bipolar disorder	5.23e-05	0.00651	CrCbGaD
Zuclopenthixol—Loxapine—DRD2—bipolar disorder	5.2e-05	0.00647	CrCbGaD
Zuclopenthixol—Perphenazine—DRD2—bipolar disorder	5.18e-05	0.00644	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—bipolar disorder	5.15e-05	0.00641	CrCbGaD
Zuclopenthixol—Clozapine—HTR1A—bipolar disorder	5.15e-05	0.0064	CrCbGaD
Zuclopenthixol—Quetiapine—DRD2—bipolar disorder	5.08e-05	0.00632	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—bipolar disorder	5.06e-05	0.0063	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2C—bipolar disorder	4.99e-05	0.0062	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR1A—bipolar disorder	4.84e-05	0.00602	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2A—bipolar disorder	4.61e-05	0.00573	CrCbGaD
Zuclopenthixol—Clozapine—DRD2—bipolar disorder	4.37e-05	0.00544	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2A—bipolar disorder	4.36e-05	0.00543	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD2—bipolar disorder	4.11e-05	0.00511	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2A—bipolar disorder	4.05e-05	0.00503	CrCbGaD
Zuclopenthixol—Loxapine—HTR2A—bipolar disorder	4.02e-05	0.005	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—bipolar disorder	4e-05	0.00498	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2A—bipolar disorder	3.92e-05	0.00488	CrCbGaD
Zuclopenthixol—Clozapine—HTR2A—bipolar disorder	3.38e-05	0.0042	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2A—bipolar disorder	3.18e-05	0.00395	CrCbGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	2.02e-05	0.000158	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—POMC—bipolar disorder	2.02e-05	0.000158	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—DRD3—bipolar disorder	2.01e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—DRD3—bipolar disorder	2.01e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—DRD2—bipolar disorder	2.01e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	2e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—HTR2A—bipolar disorder	2e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HTR1A—bipolar disorder	1.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—DRD4—bipolar disorder	1.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—POMC—bipolar disorder	1.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	1.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	1.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—POMC—bipolar disorder	1.98e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NTRK1—bipolar disorder	1.97e-05	0.000154	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	1.97e-05	0.000154	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	1.96e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	1.96e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TAC1—bipolar disorder	1.96e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	1.96e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—DRD4—bipolar disorder	1.96e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—DRD4—bipolar disorder	1.95e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	1.95e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	1.94e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	1.93e-05	0.000151	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DRD1—bipolar disorder	1.92e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HTR2C—bipolar disorder	1.92e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—S100B—bipolar disorder	1.92e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	1.92e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NDUFV2—bipolar disorder	1.9e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	1.89e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	1.89e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—HTR2A—bipolar disorder	1.89e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	1.87e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NTRK2—bipolar disorder	1.87e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DRD3—bipolar disorder	1.86e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GSK3A—bipolar disorder	1.85e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	1.84e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADCY2—bipolar disorder	1.84e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKR1C4—bipolar disorder	1.84e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	1.84e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	1.83e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	1.83e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—DRD2—bipolar disorder	1.82e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—DRD2—bipolar disorder	1.82e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	1.81e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DRD4—bipolar disorder	1.81e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	1.8e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	1.78e-05	0.000139	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	1.78e-05	0.000139	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—POMC—bipolar disorder	1.76e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—HTR2A—bipolar disorder	1.72e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CLOCK—bipolar disorder	1.72e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR1A—bipolar disorder	1.71e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADCY2—bipolar disorder	1.7e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TCF7L2—bipolar disorder	1.69e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NRG1—bipolar disorder	1.69e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TAC1—bipolar disorder	1.69e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DRD2—bipolar disorder	1.68e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TRPC3—bipolar disorder	1.68e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	1.68e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—TSHB—bipolar disorder	1.67e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—TPH2—bipolar disorder	1.67e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CACNB2—bipolar disorder	1.67e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	1.66e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR2C—bipolar disorder	1.65e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	1.65e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NR1D1—bipolar disorder	1.65e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TRPC3—bipolar disorder	1.65e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—DPYD—bipolar disorder	1.65e-05	0.000128	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	1.62e-05	0.000126	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NTRK2—bipolar disorder	1.61e-05	0.000126	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADM—bipolar disorder	1.6e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—DRD3—bipolar disorder	1.6e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GSK3A—bipolar disorder	1.6e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—POMC—bipolar disorder	1.59e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NCAN—bipolar disorder	1.58e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADM—bipolar disorder	1.58e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADM—bipolar disorder	1.57e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TACR1—bipolar disorder	1.56e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PDE4B—bipolar disorder	1.56e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TSHB—bipolar disorder	1.56e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—DRD4—bipolar disorder	1.56e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.55e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADM—bipolar disorder	1.54e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	1.54e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TSHB—bipolar disorder	1.54e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TACR1—bipolar disorder	1.54e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PDE4B—bipolar disorder	1.53e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TSHB—bipolar disorder	1.53e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TACR1—bipolar disorder	1.53e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CACNA1C—bipolar disorder	1.53e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—HTR2A—bipolar disorder	1.53e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NTRK1—bipolar disorder	1.52e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—POMC—bipolar disorder	1.51e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	1.51e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	1.51e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	1.51e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	1.5e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	1.49e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—S100B—bipolar disorder	1.48e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADCY2—bipolar disorder	1.46e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	1.46e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—DRD2—bipolar disorder	1.45e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADM—bipolar disorder	1.44e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.43e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	1.4e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	1.4e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	1.4e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	1.4e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.38e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—POMC—bipolar disorder	1.37e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—SNAP25—bipolar disorder	1.34e-05	0.000104	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NTRK1—bipolar disorder	1.31e-05	0.000102	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NRG1—bipolar disorder	1.31e-05	0.000102	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.3e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.29e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	1.28e-05	9.98e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—S100B—bipolar disorder	1.28e-05	9.96e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.27e-05	9.94e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	1.27e-05	9.94e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.27e-05	9.94e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR1A—bipolar disorder	1.27e-05	9.91e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.25e-05	9.79e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TAC1—bipolar disorder	1.25e-05	9.76e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	1.25e-05	9.76e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.25e-05	9.75e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.25e-05	9.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	1.25e-05	9.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—GSK3B—bipolar disorder	1.23e-05	9.6e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.23e-05	9.6e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.23e-05	9.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	1.23e-05	9.58e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DRD1—bipolar disorder	1.23e-05	9.58e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2C—bipolar disorder	1.23e-05	9.58e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—POMC—bipolar disorder	1.22e-05	9.52e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NTRK2—bipolar disorder	1.22e-05	9.49e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—INS—bipolar disorder	1.21e-05	9.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DRD3—bipolar disorder	1.21e-05	9.45e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GSK3A—bipolar disorder	1.2e-05	9.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	1.2e-05	9.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	1.2e-05	9.4e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.2e-05	9.33e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NTRK2—bipolar disorder	1.19e-05	9.31e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.19e-05	9.29e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DRD3—bipolar disorder	1.19e-05	9.27e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.19e-05	9.25e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ADCY2—bipolar disorder	1.18e-05	9.24e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GSK3A—bipolar disorder	1.18e-05	9.23e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HTR2A—bipolar disorder	1.18e-05	9.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DRD4—bipolar disorder	1.17e-05	9.17e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	1.17e-05	9.14e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	1.17e-05	9.1e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	1.16e-05	9.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	1.16e-05	9.06e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	1.16e-05	9.04e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.16e-05	9.02e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DRD4—bipolar disorder	1.15e-05	9e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—POMC—bipolar disorder	1.14e-05	8.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	1.14e-05	8.9e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	1.13e-05	8.83e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NRG1—bipolar disorder	1.13e-05	8.79e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.12e-05	8.76e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—bipolar disorder	1.12e-05	8.74e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.12e-05	8.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	1.12e-05	8.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	1.12e-05	8.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.11e-05	8.63e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.1e-05	8.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	1.1e-05	8.58e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.09e-05	8.51e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TPH2—bipolar disorder	1.09e-05	8.51e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TSHB—bipolar disorder	1.09e-05	8.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	1.09e-05	8.49e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.09e-05	8.49e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADCY2—bipolar disorder	1.09e-05	8.47e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.08e-05	8.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	1.08e-05	8.46e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	1.08e-05	8.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	1.08e-05	8.42e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.08e-05	8.4e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DRD2—bipolar disorder	1.07e-05	8.39e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—DPYD—bipolar disorder	1.07e-05	8.37e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	1.07e-05	8.32e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	1.06e-05	8.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	1.05e-05	8.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	1.05e-05	8.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.04e-05	8.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	1.02e-05	7.97e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.02e-05	7.96e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—bipolar disorder	1.02e-05	7.94e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR2A—bipolar disorder	1.01e-05	7.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—COMT—bipolar disorder	1.01e-05	7.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MAOA—bipolar disorder	1.01e-05	7.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	9.98e-06	7.79e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	9.97e-06	7.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NTRK1—bipolar disorder	9.91e-06	7.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	9.9e-06	7.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	9.86e-06	7.7e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	9.79e-06	7.65e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	9.75e-06	7.61e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NTRK1—bipolar disorder	9.73e-06	7.59e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	9.71e-06	7.59e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—S100B—bipolar disorder	9.63e-06	7.52e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	9.54e-06	7.45e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GSK3B—bipolar disorder	9.49e-06	7.41e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—S100B—bipolar disorder	9.47e-06	7.4e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—S100B—bipolar disorder	9.45e-06	7.38e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—bipolar disorder	9.42e-06	7.35e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—INS—bipolar disorder	9.36e-06	7.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—S100B—bipolar disorder	9.28e-06	7.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	9.27e-06	7.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	8.87e-06	6.92e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SNAP25—bipolar disorder	8.71e-06	6.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—S100B—bipolar disorder	8.62e-06	6.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NRG1—bipolar disorder	8.5e-06	6.64e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NRG1—bipolar disorder	8.36e-06	6.53e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NRG1—bipolar disorder	8.34e-06	6.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MTHFR—bipolar disorder	8.19e-06	6.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	8.19e-06	6.39e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GSK3B—bipolar disorder	8.17e-06	6.38e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—bipolar disorder	8.11e-06	6.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—INS—bipolar disorder	8.06e-06	6.29e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ADCY2—bipolar disorder	7.71e-06	6.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2A—bipolar disorder	7.66e-06	5.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	7.61e-06	5.94e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2A—bipolar disorder	7.52e-06	5.87e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	7.38e-06	5.76e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	6.86e-06	5.36e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—COMT—bipolar disorder	6.6e-06	5.16e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MAOA—bipolar disorder	6.56e-06	5.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—bipolar disorder	6.55e-06	5.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—bipolar disorder	6.51e-06	5.09e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GSK3B—bipolar disorder	6.17e-06	4.82e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—bipolar disorder	6.12e-06	4.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—bipolar disorder	6.09e-06	4.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	6.07e-06	4.74e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GSK3B—bipolar disorder	6.06e-06	4.73e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—bipolar disorder	6.02e-06	4.7e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—bipolar disorder	6.01e-06	4.69e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—bipolar disorder	5.99e-06	4.68e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—bipolar disorder	5.97e-06	4.67e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	5.94e-06	4.64e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—bipolar disorder	5.9e-06	4.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—bipolar disorder	5.86e-06	4.58e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	5.52e-06	4.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—bipolar disorder	5.48e-06	4.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—bipolar disorder	5.45e-06	4.25e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.34e-06	4.17e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—bipolar disorder	4.27e-06	3.33e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—bipolar disorder	4.25e-06	3.31e-05	CbGpPWpGaD
